EBS
Emergent BioSolutions Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -7.0% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 32.10M | $268.98M | +5 | −5 |
| Q1 2026 | 79 | +5 | 31.51M | $261.75M | +9 | −4 |
| Q4 2025 | 74 | 0 | 30.66M | $378.98M | — | — |
| Q3 2025 | 18 | +2 | 16.19M | $142.77M | +2 | — |
| Q2 2025 | 13 | 0 | 14.86M | $94.78M | — | — |
| Q1 2025 | 10 | -1 | 7.86M | $38.21M | — | −1 |
| Q4 2024 | 11 | +1 | 7.58M | $72.46M | +1 | — |
| Q3 2024 | 9 | 0 | 6.09M | $50.89M | +1 | −1 |
| Q2 2024 | 9 | — | 4.41M | $30.11M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passiv) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passiv) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passiv) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (passiv) | 1.74M | +1.8% | $11.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 1.28M | +108.9% | $8.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passiv) | 1.28M | +108.9% | $8.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 1.02M | -12.0% | $6.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.02M | -12.0% | $6.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 755.43K | -69.8% | $4.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 689.65K | -9.3% | $4.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 411.37K | +51.1% | $2.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 411.37K | +51.1% | $2.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 353.67K | -10.9% | $2.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 281.50K | -4.5% | $1.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 281.50K | -4.5% | $1.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 168.52K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 168.52K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 38.83K | +229.0% | $248,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 187 Inhaber, 43.00M Anteile, $335.12M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.